Breaking News
Get 55% Off 0
🎈 Up Big Today: Find today's biggest gainers with our free screener
Try Stock Screener
Close

Vertex Pharmaceuticals Inc (VRTX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
442.500 -1.150    -0.26%
19:46:32 - Delayed Data. Currency in EUR
  • Volume: 25
  • Bid/Ask: 442.600 / 445.200
  • Day's Range: 441.800 - 442.500
Type:  Equity
Market:  Germany
ISIN:  US92532F1003 
S/N:  882807
Vertex 442.500 -1.150 -0.26%

VRTX Recent Sentiments

 
This page features our user's sentiments regarding the Vertex Pharmaceuticals Inc stock. They are displayed on both charts of different time periods and in a detailed table.
Start Date Username Call Open Rate End Date Chg. %
May 20, 2024 Frederik Feil   410.000 Jun 14, 2024 @ 445.500 +8.66%
Apr 09, 2024 Bill Child   371.400 Apr 15, 2024 @ 376.450 +1.36%
Jan 05, 2024 Yasmina Raupova   383.000 Jan 06, 2024 @ 380.650 -0.61%
Dec 18, 2023 Siegfried Zink   370.400 Dec 18, 2023 @ 372.250 +0.50%
Nov 06, 2023 Siegfried Zink   354.650 Nov 30, 2023 @ 318.650 -10.15%
Oct 23, 2023 Trading Desk   341.950 Nov 30, 2023 @ 318.650 -6.81%
Oct 13, 2023 Yasmina Raupova   349.950 Nov 30, 2023 @ 318.650 -8.94%
Sep 22, 2023 Trading Desk   334.350 Oct 19, 2023 @ 351.750 +5.20%
Jun 28, 2023 Frederik Feil   315.850 Nov 30, 2023 @ 318.650 +0.89%
Feb 28, 2023 Mauro Legovich   270.650 Mar 24, 2023 @ 285.050 +5.32%
Jan 12, 2023 Mauro Legovich   267.600 Feb 03, 2023 @ 280.750 +4.91%
Nov 09, 2022 Werner Schmidt   303.250 Dec 02, 2022 @ 304.000 +0.25%
Nov 02, 2022 D Dow   317.200 Nov 28, 2022 @ 302.250 -4.71%
Aug 16, 2022 Philipp Schumann   300.000 Sep 09, 2022 @ 286.850 -4.38%
May 31, 2022 Michael Bleiberg   253.850 Jun 06, 2022 @ 252.300 -0.61%
Apr 18, 2022 Michael Bleiberg   270.100 Apr 25, 2022 @ 249.200 -7.74%
Mar 16, 2022 Philipp Schumann   225.850 Apr 08, 2022 @ 254.950 +12.88%
Feb 22, 2022 Tobias Schneider   196.000 Mar 18, 2022 @ 226.500 +15.56%
Feb 02, 2022 Philipp Schumann   217.950 Feb 25, 2022 @ 207.100 -4.98%
Dec 09, 2021 Xavi Pons   181.520 Dec 31, 2021 @ 198.020 +9.09%
Oct 25, 2021 מוטי בן יצחק   157.140 Nov 19, 2021 @ 162.800 +3.60%
Oct 11, 2021 Ioan Logigan   154.020 Nov 05, 2021 @ 169.000 +9.73%
Aug 06, 2021 Nico Stegy   170.720 Aug 27, 2021 @ 168.280 -1.43%
Jul 13, 2021 Pio Dro   166.520 Jul 19, 2021 @ 169.780 +1.96%
Jul 12, 2021 Kersten Henry   166.080 Aug 06, 2021 @ 170.720 +2.79%
Jul 02, 2021 Michael Bollwein   169.880 Jul 23, 2021 @ 166.800 -1.81%
Jun 11, 2021 Guido Hubert   161.000 Jul 02, 2021 @ 169.880 +5.52%
May 27, 2021 wei yu   169.000 May 31, 2021 @ 170.480 +0.88%
May 27, 2021 wei yu   169.000 May 31, 2021 @ 170.480 +0.88%
Feb 15, 2021 Daniel Schmidt   176.240 Mar 12, 2021 @ 178.160 +1.09%
Feb 10, 2021 viorel vascan   175.800 Mar 05, 2021 @ 177.760 +1.11%
Oct 16, 2020 Sergej Werner   189.980 Nov 06, 2020 @ 184.340 -2.97%
Oct 15, 2020 Dmitry Krrrrr   196.520 Nov 06, 2020 @ 184.340 -6.20%
Oct 09, 2020 EM Wei   226.000 Oct 30, 2020 @ 174.600 -22.74%
May 05, 2020 Thomas Geiser   248.250 May 29, 2020 @ 249.200 +0.38%
May 01, 2020 Gianni Gioda   226.400 May 22, 2020 @ 260.250 +14.95%
Apr 23, 2020 Jia Xu   255.400 May 15, 2020 @ 264.700 +3.64%
Mar 18, 2020 Henry Friedel   180.020 Apr 10, 2020 @ 227.200 +26.21%
Feb 21, 2020 Henry Friedel   233.100 Mar 13, 2020 @ 183.960 -21.08%
Jun 29, 2018 Hermann Albrecht   135.820 Jul 02, 2018 @ 144.470 +6.37%
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

VRTX Comments

Write your thoughts about Vertex Pharmaceuticals Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email